ALK protein expression in pulmonary adenocarcinoma of Tunisian patients

Background. It is now necessary to determine ALK status in order to use targeted therapy. Aim: herein, we assess immunohistochemical profile of ALK protein in a series of Tunisian patients with pulmonary adenocarcinoma. Materials and Methods. ALK protein expression was studied applying the D5F3 anti...

Full description

Saved in:
Bibliographic Details
Published in:Journal of immunoassay & immunochemistry Vol. 38; no. 4; pp. 411 - 419
Main Authors: Arfaoui, Amira Toumi, Blel, Ahlem, Aloui, Raoudha, Fatnassi, Ghaya, Ammar, Jihane Ben, Znaidi, Nadia, Zidi, Yosra, Boudaya, Mohammed Sadok, Aouina, Hichem, Rammeh Rommani, Soumaya
Format: Journal Article
Language:English
Published: England Taylor & Francis 04-07-2017
Marcel Dekker, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background. It is now necessary to determine ALK status in order to use targeted therapy. Aim: herein, we assess immunohistochemical profile of ALK protein in a series of Tunisian patients with pulmonary adenocarcinoma. Materials and Methods. ALK protein expression was studied applying the D5F3 antibody with a fully automated Ventana CDx technique on a series of 19 patients. Results. Positive ALK expression was found in one case (5.2%) corresponding to a papillary adenocarcinoma which showed a strong granular and homogenous cytoplasmic staining. The patient was a 30-years-old woman. Conclusion. The frequency of positive ALK expression based on immunohistochemistry in our series was similar to that reported in the world literature.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1532-1819
1532-4230
DOI:10.1080/15321819.2017.1319860